Actinium Pharmaceuticals ATNM
NYSE ATNM
$1.18 +0.03 (+2.61%)
As of: Oct 2, 2026 · 12:51 PM EDT

Actinium Pharmaceuticals (ATNM) Accumulated Depreciation (2019 - 2024)

Updated

Actinium Pharmaceuticals' Accumulated Depreciation came in at $891,000 for Q4 2024, up 28.4% from $694,000 a year earlier.

Analysis

Actinium Pharmaceuticals (ATNM) Accumulated Depreciation (2019 - 2024) Analysis & Trends

Going back to Q4 2019, Actinium Pharmaceuticals' Accumulated Depreciation data covers 4 quarters.

  • Accumulated Depreciation carries a five-year compound annual growth rate of 30.3% (FY2019 to FY2024).
  • Going back by year, Accumulated Depreciation was $694,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Actinium Pharmaceuticals 36.16 Mn 36.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 891,000.00
Dec 31, 2023 694,000.00
Mar 31, 2020 249,000.00
Dec 31, 2019 237,000.00
API Access

Actinium Pharmaceuticals Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=ATNM&period=max&api_key=YOUR_API_KEY